Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (471-480 of 517) with videos related to

Pageof 52
Sort By:
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Biological Psychiatry|September 6, 2005
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trialA John Rush, Lauren B Marangell, Harold A Sackeim, et al.
Molecular & Cellular Proteomics : MCP|February 21, 2012
TSLP signaling network revealed by SILAC-based phosphoproteomicsJun Zhong, Min-Sik Kim, Raghothama Chaerkady, et al.
The American Journal of Psychiatry|November 1, 2006
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportA John Rush, Madhukar H Trivedi, Stephen R Wisniewski, et al.
Journal of Youth and Adolescence|July 12, 2014
Course and Severity of Maternal Depression: Associations with Family Functioning and Child AdjustmentCynthia Ewell Foster, Melissa C Webster, Myrna M Weissman, et al.
Science Translational Medicine|August 6, 2010
Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitorsJannik N Andersen, Sriram Sathyanarayanan, Alessandra Di Bacco, et al.
Archives of General Psychiatry|March 7, 2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depressionMichael E Thase, A John Rush, Robert H Howland, et al.
Journal of Affective Disorders|January 23, 2025
Psychometric properties of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in adolescent and young adult psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)John R Jeevarajan, Arrian Theodorou, Karabi Nandy, et al.
Psychotherapy and Psychosomatics|August 16, 2018
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC TrialMadhukar H Trivedi, Charles South, Manish K Jha, et al.
The New England Journal of Medicine|January 26, 2021
Bupropion and Naltrexone in Methamphetamine Use DisorderMadhukar H Trivedi, Robrina Walker, Walter Ling, et al.
Pageof 52

Showing results (471-480 of 517) with videos related to

Sort By:
Pageof 52
Archives of General Psychiatry|September 9, 2009
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionMarcus Ising, Susanne Lucae, Elisabeth B Binder, et al.
Biological Psychiatry|September 6, 2005
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trialA John Rush, Lauren B Marangell, Harold A Sackeim, et al.
Molecular & Cellular Proteomics : MCP|February 21, 2012
TSLP signaling network revealed by SILAC-based phosphoproteomicsJun Zhong, Min-Sik Kim, Raghothama Chaerkady, et al.
The American Journal of Psychiatry|November 1, 2006
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportA John Rush, Madhukar H Trivedi, Stephen R Wisniewski, et al.
Journal of Youth and Adolescence|July 12, 2014
Course and Severity of Maternal Depression: Associations with Family Functioning and Child AdjustmentCynthia Ewell Foster, Melissa C Webster, Myrna M Weissman, et al.
Science Translational Medicine|August 6, 2010
Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitorsJannik N Andersen, Sriram Sathyanarayanan, Alessandra Di Bacco, et al.
Archives of General Psychiatry|March 7, 2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depressionMichael E Thase, A John Rush, Robert H Howland, et al.
Journal of Affective Disorders|January 23, 2025
Psychometric properties of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in adolescent and young adult psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)John R Jeevarajan, Arrian Theodorou, Karabi Nandy, et al.
Psychotherapy and Psychosomatics|August 16, 2018
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC TrialMadhukar H Trivedi, Charles South, Manish K Jha, et al.
The New England Journal of Medicine|January 26, 2021
Bupropion and Naltrexone in Methamphetamine Use DisorderMadhukar H Trivedi, Robrina Walker, Walter Ling, et al.
Pageof 52